• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
China

The WHO says it’s not yet seeing new COVID variants in China—but data ‘underrepresent’ deaths

Nicholas Gordon
By
Nicholas Gordon
Nicholas Gordon
Asia Editor
Down Arrow Button Icon
Nicholas Gordon
By
Nicholas Gordon
Nicholas Gordon
Asia Editor
Down Arrow Button Icon
January 5, 2023, 4:36 AM ET
Mike Ryan, the WHO's executive director for health emergencies, said Chinese data "underrepresent" the true extent of China's COVID outbreak during a Wednesday media briefing.
Mike Ryan, the WHO's executive director for health emergencies, said Chinese data "underrepresent" the true extent of China's COVID outbreak during a Wednesday media briefing. Fabrice Coffrini—AFP via Getty Images

Governments like the U.S. Say they’re worried about the rise of new variants in China’s massive COVID outbreak, but the World Health Organization says it has yet to see any new strains in the country.

In a statement released Wednesday, the WHO said that a sample of genomic data provided by China’s Center for Disease Control and Prevention reported that almost all cases were of BA.5.2 and BF.7 strains, which are two variants of Omicron. 

“These variants are known and have been circulating in other countries, and at present time no new variant has been reported by the China CDC,” the WHO said in its statement.

The WHO noted that the data from the China CDC matches what has been reported by other countries regarding arrivals from China. Last week, Italian health authorities said that half the passengers on two planes from China tested positive for COVID, but prime minister Giorgia Meloni later shared that all those who tested positive had already-known strains of Omicron.

Foreign governments have criticized China’s limited sharing of genomic data, warning that it would limit surveillance for new immune-evasive COVID variants. 

The U.S. Will start requiring negative test results for passengers on flights originating from China on Thursday. The new testing requirement was imposed in part due to “the lack of adequate and transparent epidemiological and viral genomic sequence data,” U.S. State Department spokesperson Ned Price said at a media briefing on Tuesday.

China has called these travel restrictions “unacceptable” and say they “lack scientific basis.” 

‘Underrepresent the true impact of the disease’

The World Health Organization in its statement highlighted “the critical need for and importance of additional analysis as well as sharing of sequence data to understand the evolution of SARS-CoV-2 and the emergence of concerning mutations or variants.”

In a separate briefing, WHO officials said that Chinese data minimized the true scope of its COVID outbreak. 

Current Chinese numbers “underrepresent the true impact of the disease,” especially regarding hospitalizations and deaths, said Mike Ryan, the WHO’s executive director for health emergencies. 

China narrowed its definition of a COVID death in December, choosing only to count COVID patients who specifically died from respiratory failure or pneumonia as “COVID deaths.” Yet a slew of obituaries of prominent businesspeople, academics, and celebrities imply a broader and more deadly outbreak, reports the Financial Times. 

“We continue to ask China for more rapid, regular, reliable data on hospitalizations and deaths, as well as more comprehensive, real-time viral sequencing,” WHO director-general Tedros Adhanom Ghebreyesus, said at the briefing. 

Our new weekly Impact Report newsletter examines how ESG news and trends are shaping the roles and responsibilities of today's executives. Subscribe here.

About the Author
Nicholas Gordon
By Nicholas GordonAsia Editor
LinkedIn iconTwitter icon

Nicholas Gordon is an Asia editor based in Hong Kong, where he helps to drive Coins2Day’s coverage of Asian business and economics news.

See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.